{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:43:51Z","timestamp":1761489831760},"reference-count":24,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,3]]},"abstract":"<jats:p>The health-care needs and resources of disease-endemic regions such as west Africa have been a major focus during the recent Ebola outbreak. On the basis of that experience, we call attention to two priorities that have unfortunately been ignored thus far: 1) the development of clinical research facilities and 2) the training of host country investigators to ensure that the facilities and expertise necessary to evaluate candidate interventions are available on-site in endemic regions when and where they are needed. In their absence, as illustrated by the recent uncertainty about the use of antivirals and other interventions for Ebola virus disease, the only treatment available may be supportive care, case fatality rates may be unacceptably high and there may be long delays between the time potential interventions become available and it becomes clear whether those interventions are safe or effective. On the basis of our experience in Mali, we urge that the development of clinical research facilities and the training of host country investigators be prioritized in disease-endemic regions such as west Africa.<\/jats:p>","DOI":"10.4269\/ajtmh.15-0366","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T03:15:54Z","timestamp":1448334954000},"page":"253-257","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Research and the Training of Host Country Investigators: Essential Health Priorities for Disease-Endemic Regions"],"prefix":"10.4269","volume":"94","author":[{"given":"Ousmane A.","family":"Koita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar\u00e9","family":"Fongoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boubakar","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seydou O.","family":"Doumbia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moussa","family":"Traor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald J.","family":"Krogstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"ref1","series-title":"J Gen Virol","first-page":"1619","article-title":"The 2014 Ebola virus disease outbreak in West Africa","volume":"95","author":"Gatherer","year":"2014"},{"key":"ref2","series-title":"Nature","first-page":"126","article-title":"Barriers to trust: an outbreak of Ebola highlights the difficulties of implementing public health measures","volume":"511","author":"Anonymous","year":"2014"},{"key":"ref3","series-title":"Nature","first-page":"233","article-title":"Scale up the supply of experimental drugs: estimates of the probable impact of the outbreak show that existing stocks of potentially useful medicines are insufficient","volume":"512","author":"Brady","year":"2014"},{"key":"ref4","series-title":"Vaccine","first-page":"5846","article-title":"The gold industry standard for risk and cost of drug and vaccine development revisited","volume":"29","author":"Pronker","year":"2011"},{"key":"ref5","series-title":"Health Policy","first-page":"4","article-title":"The cost of drug development: a systematic review","volume":"100","author":"Morgan","year":"2011"},{"key":"ref6","series-title":"Nature","first-page":"520","article-title":"Ebola treatments caught in limbo","volume":"511","author":"Reardon","year":"2014"},{"year":"1996","series-title":"Guidance for Industry, E6 Good Clinical Practice: Consolidated Guidance","author":"Anonymous","key":"ref7"},{"year":"2005","series-title":"International Conference on Harmonisation (ICH) Guideline for Good Clinical Practice","author":"Anonymous","key":"ref8"},{"year":"2005","series-title":"Health Expenditure Per Capita, by Country, 1995\u20132013","author":"WHO","key":"ref9"},{"key":"ref10","series-title":"Am J Trop Med Hyg","first-page":"579","article-title":"Aminoquinolines that circumvent chloroquine resistance in Plasmodium falciparum in vitro","volume":"55","author":"De","year":"1996"},{"key":"ref11","series-title":"PLoS Clin Trials","first-page":"e6","article-title":"Randomized, dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers","volume":"2","author":"Mzayek","year":"2007"},{"issue":"Suppl","key":"ref12","series-title":"Trans R Soc Trop Med Hyg","first-page":"39","article-title":"The current state of studies of malaria vectors and the antivectorial campaign in West Africa","volume":"83","author":"Tour\u00e9","year":"1989"},{"issue":"Suppl","key":"ref13","series-title":"Am J Trop Med Hyg","first-page":"116","article-title":"Genetic approaches to malaria control: how long the road?","volume":"50","author":"Gwadz","year":"1994"},{"year":"2015","series-title":"Studies of a Candidate Aminoquinoline Antimalarial (AQ-13)","author":"Krogstad","key":"ref14"},{"key":"ref15","series-title":"J Infect Dis","first-page":"791","article-title":"Intravascular hemolysis, nitric oxide consumption and pulmonary hypertension in children with severe malarial anemia","volume":"202","author":"Koita","year":"2010"},{"key":"ref16","series-title":"Lancet","first-page":"637","article-title":"Ebola: a failure of international collective action","volume":"384","author":"Anonymous","year":"2014"},{"issue":"Suppl 2","key":"ref17","series-title":"J Infect Dis","first-page":"S142","article-title":"Assessment of the risk of Ebola virus transmission from bodily fluids and fomites","volume":"196","author":"Bausch","year":"2007"},{"key":"ref18","series-title":"J Med Virol","first-page":"463","article-title":"Diagnosis of Ebola haemorrrhagic fever by RT-PCR in an epidemic setting","volume":"60","author":"Leroy","year":"2000"},{"key":"ref19","series-title":"J Virol","first-page":"4330","article-title":"Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome","volume":"78","author":"Towner","year":"2004"},{"key":"ref20","series-title":"J Clin Microbiol","first-page":"2323","article-title":"Rapid detection and quantification of RNA of Ebola and Marburg viruses, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR","volume":"40","author":"Drosten","year":"2002"},{"key":"ref21","series-title":"Lancet","first-page":"481","article-title":"WHO and partners launch Ebola response plan","volume":"384","author":"Green","year":"2014"},{"key":"ref22","series-title":"Clin Vaccine Immunol","first-page":"1267","article-title":"A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial","volume":"13","author":"Martin","year":"2006"},{"key":"ref23","series-title":"PLoS One","first-page":"e2","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007"},{"key":"ref24","series-title":"Lancet","first-page":"857","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/94\/2\/article-p253.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/94\/2\/article-p253.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/94\/2\/article-p253.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T22:14:27Z","timestamp":1723068867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/94\/2\/article-p253.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,3]]},"references-count":24,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.15-0366","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"type":"print","value":"0002-9637"},{"type":"electronic","value":"1476-1645"}],"subject":[],"published":{"date-parts":[[2016,2,3]]}}}